Effect of graft-versus-host disease prophylaxis on 3-year disease-free survival in recipients of unrelated donor bone marrow (T-cell Depletion Trial): a multi-centre …
JE Wagner, JS Thompson, SL Carter, NA Kernan - The Lancet, 2005 - thelancet.com
Background Graft-versus-host disease (GVHD) reduces the efficacy of unrelated donor bone
marrow transplantation in patients with lymphohaemopoietic malignancy. A multi-centre …
marrow transplantation in patients with lymphohaemopoietic malignancy. A multi-centre …
[引用][C] Effect of graft-versus-host disease prophylaxis on 3-year disease-free survival in recipients of unrelated donor bone marrow (T-cell Depletion trial): a multi …
JE WAGNER, JS THOMPSON… - Lancet (British …, 2005 - pascal-francis.inist.fr
Effect of graft-versus-host disease prophylaxis on 3-year disease-free survival in recipients
of unrelated donor bone marrow (T-cell Depletion trial) : a multi-centre, randomised phase II-III …
of unrelated donor bone marrow (T-cell Depletion trial) : a multi-centre, randomised phase II-III …
Effect of graft-versus-host disease prophylaxis on 3-year disease-free survival in recipients of unrelated donor bone marrow (T-cell Depletion Trial): a multi-centre …
JE Wagner, JS Thompson, SL Carter… - Lancet (London …, 2005 - europepmc.org
Background Graft-versus-host disease (GVHD) reduces the efficacy of unrelated donor bone
marrow transplantation in patients with lymphohaemopoietic malignancy. A multi-centre …
marrow transplantation in patients with lymphohaemopoietic malignancy. A multi-centre …
Effect of graft-versus-host disease prophylaxis on 3-year disease-free survival in recipients of unrelated donor bone marrow (T-cell Depletion Trial): a multi-centre …
JE Wagner, JS Thompson, SL Carter… - Lancet (London …, 2005 - pubmed.ncbi.nlm.nih.gov
Background Graft-versus-host disease (GVHD) reduces the efficacy of unrelated donor bone
marrow transplantation in patients with lymphohaemopoietic malignancy. A multi-centre …
marrow transplantation in patients with lymphohaemopoietic malignancy. A multi-centre …
[PDF][PDF] Effect of graft-versus-host disease prophylaxis on 3-year disease-free survival in recipients of unrelated donor bone marrow (T-cell Depletion Trial): a multi …
M Sloan-Kettering - Lancet, 2005 - Citeseer
Background Graft-versus-host disease (GVHD) reduces the efficacy of unrelated donor bone
marrow transplantation in patients with lymphohaemopoietic malignancy. A multi-centre …
marrow transplantation in patients with lymphohaemopoietic malignancy. A multi-centre …
Effect of graft-versus-host disease prophylaxis on 3-year disease-free survival in recipients of unrelated donor bone marrow (T-cell Depletion Trial): a multi-centre …
JE Wagner, JS Thompson, SL Carter, NA Kernan - The Lancet, 2005 - Elsevier
BACKGROUND: Graft-versus-host disease (GVHD) reduces the efficacy of unrelated donor
bone marrow transplantation in patients with lymphohaemopoietic malignancy. A multi …
bone marrow transplantation in patients with lymphohaemopoietic malignancy. A multi …
Effect of graft-versus-host disease prophylaxis on 3-year disease-free survival in recipients of unrelated donor bone marrow (T-cell Depletion Trial): A multi-centre …
JE Wagner, JS Thompson, SL Carter, NA Kernan - Lancet, 2005 - experts.umn.edu
Background: Graft-versus-host disease (GVHD) reduces the efficacy of unrelated donor
bone marrow transplantation in patients with lymphohaemopoietic malignancy. A multi …
bone marrow transplantation in patients with lymphohaemopoietic malignancy. A multi …
Effect of graft-versus-host disease prophylaxis on 3-year disease-free survival in recipients of unrelated donor bone marrow (T-cell Depletion Trial): a multi-centre …
JE Wagner, JS Thompson, SL Carter, NA Kernan - The Lancet, 2005 - thelancet.com
Background Graft-versus-host disease (GVHD) reduces the efficacy of unrelated donor bone
marrow transplantation in patients with lymphohaemopoietic malignancy. A multi-centre …
marrow transplantation in patients with lymphohaemopoietic malignancy. A multi-centre …
Effect of graft-versus-host disease prophylaxis on 3-year disease-free survival in recipients of unrelated donor bone marrow (T-cell Depletion Trial): a multi-centre …
JE Wagner, JS Thompson, SL Carter, NA Kernan - The Lancet, 2005 - infona.pl
Graft-versus-host disease (GVHD) reduces the efficacy of unrelated donor bone marrow
transplantation in patients with lymphohaemopoietic malignancy. A multi-centre, randomised …
transplantation in patients with lymphohaemopoietic malignancy. A multi-centre, randomised …
[引用][C] Effect of graft-versus-host disease prophylaxis on 3-year disease-free survival in recipients of unrelated donor bone marrow (T-cell Depletion Trial): a …
W JE - Lancet, 2005 - cir.nii.ac.jp
Effect of graft-versus-host disease prophylaxis on 3-year disease-free survival in recipients of
unrelated donor bone marrow (T-cell Depletion Trial) : a multicentre, randomised phase II-III …
unrelated donor bone marrow (T-cell Depletion Trial) : a multicentre, randomised phase II-III …